|
Useful links about ATMPs
|
|
0
|
107
|
June 25, 2024
|
|
Webinar: Gene therapy long-term follow-up studies
|
|
0
|
25
|
November 24, 2025
|
|
How to manage the long-term follow-up requirements for ATMPs?
|
|
2
|
115
|
September 15, 2025
|
|
Denmark and Germany Publish National ATMP Strategies – Time for NL?
|
|
1
|
53
|
September 15, 2025
|
|
European Study on the Hospital Exemption out
|
|
0
|
102
|
August 15, 2025
|
|
Committee for Advanced Therapies (CAT) workshop on gene editing
|
|
0
|
43
|
July 28, 2025
|
|
Navigating the CRISPR/Cas9 Patent Maze
|
|
1
|
64
|
July 21, 2025
|
|
Advanced Therapies Europe | Event
|
|
0
|
32
|
July 15, 2025
|
|
TechTalk XL - Cell & Gene Therapies (Leiden)
|
|
0
|
47
|
June 18, 2025
|
|
How do clinical study requirements for ATMPs differ from others?
|
|
2
|
81
|
June 13, 2025
|
|
First FDA platform technology designation, how to move from progress for one to potential for many?
|
|
0
|
20
|
June 6, 2025
|
|
Quality by Design for ATMPs?
|
|
0
|
45
|
May 30, 2025
|
|
Platforms technologies: CBG Science Day meets first In Vivo base editor case
|
|
0
|
31
|
May 19, 2025
|
|
Decentralized Cell Therapy Manufacturing Webinar
|
|
0
|
43
|
May 12, 2025
|
|
Gene Therapy Trial Browser
|
|
0
|
44
|
May 2, 2025
|
|
ADVANCE 5-day Summer School on Cell and Gene Therapies
|
|
0
|
44
|
April 14, 2025
|
|
Guidebook for the development of ATMPs
|
|
0
|
61
|
January 8, 2025
|
|
FAST ATMP webinar part 3 - Market authorization, hospital exemptions, reimbursement
|
|
2
|
70
|
April 1, 2025
|
|
FAST ATMP webinar part 2 - Non-clinical development, clinical development, Regulation and legislation
|
|
2
|
86
|
April 1, 2025
|
|
FAST ATMP Webinar part 1 - Patient participation, classification of ATMPs, product development
|
|
2
|
142
|
April 1, 2025
|
|
Is there a guidance document for ATMPs during process changes or manufacturing scale-up?
|
|
1
|
59
|
March 19, 2025
|
|
Is there a format or guidance document for writing a product development plan and IMPD specifically for ATMPs
|
|
3
|
65
|
March 14, 2025
|
|
DARE-NL Annual Consortium Meeting
|
|
0
|
29
|
March 14, 2025
|
|
Online information about Gene Therapy for monogenic diseases - for patients
|
|
0
|
41
|
March 11, 2025
|
|
How can the lack of formal documentation in patient involvement activities be addressed?
|
|
4
|
121
|
March 11, 2025
|
|
Dutch ATMP summit
|
|
0
|
50
|
December 12, 2024
|
|
CAT template examples
|
|
2
|
88
|
February 14, 2025
|
|
Exploring Academic ATMP Development: Insights from Belgium & Comparisons with the Netherlands
|
|
0
|
33
|
February 14, 2025
|
|
EU HTA regulation impact and ATMP market access?
|
|
0
|
57
|
February 5, 2025
|
|
Regulatory expectations for potency assays
|
|
0
|
49
|
January 23, 2025
|